Loading…
Based on limited metadata, Spectrum Laboratory Products received an FDA Warning Letter on June 4, 2019, regarding drug manufacturing or distribution operations. Without access to the full letter text or a specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product oversight and enforcement authority. To understand the specific compliance issues cited, the complete Warning Letter document would need to be reviewed.